An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains.
The immune system of people with celiac disease mistakenly identifies parts of gliadin and glutenin as foreign and destroys them. The immune system usually looks for “foreign” epitopes—parts of ...